These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 31938048)

  • 21. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
    Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
    Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Knockdown of endothelin receptor B inhibits the progression of triple-negative breast cancer.
    Gu X; Han S; Cui M; Xue J; Ai L; Sun L; Zhu X; Wang Y; Liu C
    Ann N Y Acad Sci; 2019 Jul; 1448(1):5-18. PubMed ID: 30900271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin.
    Hugo HJ; Gunasinghe NPAD; Hollier BG; Tanaka T; Blick T; Toh A; Hill P; Gilles C; Waltham M; Thompson EW
    Breast Cancer Res; 2017 Jul; 19(1):86. PubMed ID: 28750639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Moderate intermittent negative pressure increases invasiveness of MDA-MB-231 triple negative breast cancer cells.
    Liu W; Fu X; Yang Z; Li S; Cao Y; Li Q; Luan J
    Breast; 2018 Apr; 38():14-21. PubMed ID: 29182982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular heterogeneity in breast carcinoma cells with increased invasive capacities.
    Negro G; Aschenbrenner B; Brezar SK; Cemazar M; Coer A; Gasljevic G; Savic D; Sorokin M; Buzdin A; Callari M; Kvitsaridze I; Jewett A; Vasileva-Slaveva M; Ganswindt U; Skvortsova I; Skvortsov S
    Radiol Oncol; 2020 Feb; 54(1):103-118. PubMed ID: 32061169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ensemble clustering of phosphoproteomic data identifies differences in protein interactions and cell-cell junction integrity of HER2-overexpressing cells.
    Schaberg KE; Shirure VS; Worley EA; George SC; Naegle KM
    Integr Biol (Camb); 2017 Jun; 9(6):539-547. PubMed ID: 28492659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ErbB2, EphrinB1, Src kinase and PTPN13 signaling complex regulates MAP kinase signaling in human cancers.
    Vermeer PD; Bell M; Lee K; Vermeer DW; Wieking BG; Bilal E; Bhanot G; Drapkin RI; Ganesan S; Klingelhutz AJ; Hendriks WJ; Lee JH
    PLoS One; 2012; 7(1):e30447. PubMed ID: 22279592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Geminin overexpression-dependent recruitment and crosstalk with mesenchymal stem cells enhance aggressiveness in triple negative breast cancers.
    Ananthula S; Sinha A; El Gassim M; Batth S; Marshall GD; Gardner LH; Shimizu Y; ElShamy WM
    Oncotarget; 2016 Apr; 7(15):20869-89. PubMed ID: 26989079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Claudin 1 inhibits cell migration and increases intercellular adhesion in triple-negative breast cancer cell line.
    Geoffroy M; Kleinclauss A; Kuntz S; Grillier-Vuissoz I
    Mol Biol Rep; 2020 Oct; 47(10):7643-7653. PubMed ID: 32979166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual Role of the PTPN13 Tyrosine Phosphatase in Cancer.
    Mcheik S; Aptecar L; Coopman P; D'Hondt V; Freiss G
    Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33322542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated tumor LDLR expression accelerates LDL cholesterol-mediated breast cancer growth in mouse models of hyperlipidemia.
    Gallagher EJ; Zelenko Z; Neel BA; Antoniou IM; Rajan L; Kase N; LeRoith D
    Oncogene; 2017 Nov; 36(46):6462-6471. PubMed ID: 28759039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Norstictic Acid Inhibits Breast Cancer Cell Proliferation, Migration, Invasion, and In Vivo Invasive Growth Through Targeting C-Met.
    Ebrahim HY; Elsayed HE; Mohyeldin MM; Akl MR; Bhattacharjee J; Egbert S; El Sayed KA
    Phytother Res; 2016 Apr; 30(4):557-66. PubMed ID: 26744260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppression of Her2/Neu mammary tumor development in mda-7/IL-24 transgenic mice.
    Li YJ; Liu G; Xia L; Xiao X; Liu JC; Menezes ME; Das SK; Emdad L; Sarkar D; Fisher PB; Archer MC; Zacksenhaus E; Ben-David Y
    Oncotarget; 2015 Nov; 6(35):36943-54. PubMed ID: 26460950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of the tumor suppressor gene phosphatase and tensin homologue partially inhibits wnt-1-induced mammary tumorigenesis.
    Zhao H; Cui Y; Dupont J; Sun H; Hennighausen L; Yakar S
    Cancer Res; 2005 Aug; 65(15):6864-73. PubMed ID: 16061670
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PRAME promotes epithelial-to-mesenchymal transition in triple negative breast cancer.
    Al-Khadairi G; Naik A; Thomas R; Al-Sulaiti B; Rizly S; Decock J
    J Transl Med; 2019 Jan; 17(1):9. PubMed ID: 30602372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of HJ-PI01 as a novel Pim-2 inhibitor that induces apoptosis and autophagic cell death in triple-negative human breast cancer.
    Zhao YQ; Yin YQ; Liu J; Wang GH; Huang J; Zhu LJ; Wang JH
    Acta Pharmacol Sin; 2016 Sep; 37(9):1237-50. PubMed ID: 27397540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-22 promotes development of malignant lesions in a mouse model of spontaneous breast cancer.
    Katara GK; Kulshrestha A; Schneiderman S; Riehl V; Ibrahim S; Beaman KD
    Mol Oncol; 2020 Jan; 14(1):211-224. PubMed ID: 31725949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In Vivo Selection of Intermediately- and Highly-Malignant Variants of Triple-negative Breast Cancer in Orthotopic Nude Mouse Models.
    Yano S; Takehara K; Kishimoto H; Tazawa H; Urata Y; Kagawa S; Bouvet M; Fujiwara T; Hoffman RM
    Anticancer Res; 2016 Dec; 36(12):6273-6277. PubMed ID: 27919946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities.
    Tan M; Yao J; Yu D
    Cancer Res; 1997 Mar; 57(6):1199-205. PubMed ID: 9067293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HOXB7 promotes malignant progression by activating the TGFβ signaling pathway.
    Liu S; Jin K; Hui Y; Fu J; Jie C; Feng S; Reisman D; Wang Q; Fan D; Sukumar S; Chen H
    Cancer Res; 2015 Feb; 75(4):709-19. PubMed ID: 25542862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.